Hartl L; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Gompelmann D; Szekeres T; Quehenberger P; Trauner M; Mandorfer M; Scheiner B; Reiberger T, 2021. Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19.  J Pers Med 11.

Mandorfer M; Simbrunner B, 2021. Prevention of First Decompensation in Advanced Chronic Liver Disease.  Clin Liver Dis 25(2):291-310

Semmler G; Binter T; Kozbial K; Schwabl P; Hametner-Schreil S; Zanetto A; Gavasso S; Chromy D; Bauer DJM; Simbrunner B; Scheiner B; Bucsics T; Stättermayer AF; Pinter M; Steindl-Munda P; Schöfl R; Russo FP; Simioni P; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2021. Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease.  Hepatology 73(4):1275-1289

Bauer D; Farthofer A; Chromy D; Simbrunner B; Steininger L; Schmidbauer C; Binter T; Trauner M; Mandorfer M; Schmidt R; Mayer F; Holzmann H; Strassl R; Reiberger T, 2021. Recent outbreaks of severe hepatitis A virus infections in Vienna.  Eur J Clin Microbiol Infect Dis 40(2):335-344

Simbrunner B; Stadlmann A; Schwabl P; Paternostro R; Bauer DJM; Bucsics T; Scheiner B; Lampichler K; Wöran K; Beer A; Eigenbauer E; Pinter M; Stättermayer AF; Marculescu R; Szekeres T; Trauner M; Mandorfer M; Reiberger T, 2021. Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver disease.  Dig Liver Dis 53(3):345-352

Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2021. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.  J Hepatol 74(4):819-828

Jachs M; Hartl L; Schaufler D; Desbalmes C; Simbrunner B; Eigenbauer E; Bauer DJM; Paternostro R; Schwabl P; Scheiner B; Bucsics T; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2021. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes.  Gut 70(9):1758-1767

Burghart L; Halilbasic E; Schwabl P; Simbrunner B; Stättermayer AF; Petrenko O; Scheiner B; Bauer D; Pinter M; Boztug K; Mandorfer M; Trauner M; Reiberger T, 2021. Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.  J Gastroenterol.

Steininger L; Chromy D; Bauer D; Simbrunner B; Binter T; Schwabl P; Schmidbauer C; Trauner M; Gschwantler M; Mandorfer M; Reiberger T, 2021. Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence.  Wien Klin Wochenschr 133(9-10):452-460

Trebicka J; Gu W; de Ledinghen V; Aubé C; Krag A; Praktiknjo M; Castera L; Dumortier J; Bauer DJM; Friedrich-Rust M; Pol S; Grgurevic I; Zheng R; Francque S; Gottfriedovà H; Mustapic S; Sporea I; Berzigotti A; Uschner FE; Simbrunner B; Ronot M; Cassinotto C; Kjaergaard M; Andrade F; Schulz M; Semmler G; Drinkovic IT; Chang J; Brol MJ; Rautou PE; Vanwolleghem T; Strassburg CP; Boursier J; Ferstl PG; Rasmussen DN; Reiberger T; Vilgrain V; Guibal A; Guillaud O; Zeuzem S; Vassord C; Lu X; Vonghia L; Senkerikova R; Popescu A; Margini C; Wang W; Thiele M; Jansen C, 2021. Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease.  Gut.

Costa D; Simbrunner B; Reiberger T, 2021. Reply to: "Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease".  J Hepatol 74(4):1000-1001

Raeven P; Mandorfer M; Baron DM; Reiberger T; Simbrunner B, 2021. Author's reply to "Thromboelastometry in patients with advanced chronic liver disease: a complex interplay".  Hepatol Int 15(2):522-524

Haslacher H; Rappel R; Thalhammer R; Demyanets S; Simbrunner B; Reiberger T; Eberhard S; Schwarzinger I, 2021. Adequate scattergram interpretation increases the reliability of automated polymorphonuclear (pmn) cell counts from ascitic fluid of patients with liver cirrhosis.  Int J Lab Hematol 43(4):O176-O180

Starlinger P; Ahn JC; Mullan A; Gyoeri GP; Pereyra D; Alva-Ruiz R; Hackl H; Reiberger T; Trauner M; Santol J; Simbrunner B; Mandorfer M; Berlakovich G; Kamath PS; Heimbach J, 2021. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.  Hepatology 74(3):1533-1545

Paternostro R; Bardach C; Hofer BS; Scheiner B; Schwabl P; Asenbaum U; Ba-Ssalamah A; Scharitzer M; Bucscis T; Simbrunner B; Bauer D; Trauner M; Mandorfer M; Reiberger T; Lampichler K, 2021. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension.  Liver Int 41(4):799-809

Simbrunner B; Costa D; Reiberger T, 2021. Reply to: "Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease".  J Hepatol 75(1):234-236

Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Schwabl P; Stättermayer AF; Pinter M; Eigenbauer E; Quehenberger P; Trauner M; Reiberger T; Mandorfer M, 2021. Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death.  Clin Gastroenterol Hepatol.

Semmler G; Meyer EL; Kozbial K; Schwabl P; Hametner-Schreil S; Zanetto A; Bauer D; Chromy D; Simbrunner B; Scheiner B; Stättermayer AF; Pinter M; Schöfl R; Russo FP; Greenfield H; Schwarz M; Schwarz C; Gschwantler M; Alonso López S; Manzano ML; Ahumada A; Bañares R; Pons M; Rodriguez-Tajes S; Genesca J; Lens S; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2021. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.  J Hepatol.

Semmler G; Binter T; Kozbial K; Schwabl P; Chromy D; Bauer D; Simbrunner B; Müllner-Bucsics T; Scheiner B; Stättermayer A; Pinter M; Steindl-Munda P; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2021. Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR.  J Pers Med 11.

Königshofer P; Hofer BS; Brusilovskaya K; Simbrunner B; Petrenko O; Wöran K; Herac M; Stift J; Lampichler K; Timelthaler G; Bauer D; Hartl L; Robl B; Sibila M; Podesser BK; Oberhuber G; Schwabl P; Mandorfer M; Trauner M; Reiberger T, 2021. Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies.  Hepatology.

Simbrunner B; Trauner M; Reiberger T, 2021. Review article: therapeutic aspects of bile acid signalling in the gut-liver axis.  Aliment Pharmacol Ther 54(10):1243-1262

Schmidbauer C; Chromy D; Schmidbauer VU; Schwarz M; Jachs M; Bauer DJM; Binter T; Apata M; Nguyen DT; Mandorfer M; Simbrunner B; Rieger A; Mayer F; Breuer M; Strassl R; Schmidt R; Holzmann H; Trauner M; Gschwantler M; Reiberger T, 2021. Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients.  Liver Int 41(11):2622-2634

Paternostro R; Becker J; Hofer BS; Panagl V; Schiffke H; Simbrunner B; Semmler G; Schwabl P; Scheiner B; Bucsics T; Bauer D; Binter T; Trauner M; Mandorfer M; Reiberger T, 2021. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices.  Dig Liver Dis.

Hartl L; Semmler G; Hofer BS; Schirwani N; Jachs M; Simbrunner B; Bauer DJM; Binter T; Pomej K; Pinter M; Trauner M; Mandorfer M; Reiberger T; Scheiner B, 2021. COVID-19-Related Downscaling of In-Hospital Liver Care Decreased Patient Satisfaction and Increased Liver-Related Mortality.  Hepatol Commun 5(10):1660-1675

Jachs M; Binter T; Chromy D; Schalk H; Pichler K; Bauer D; Simbrunner B; Hartl L; Schmidbauer C; Mayer F; Strassl R; Mandorfer M; Gschwantler M; Reiberger T, 2021. Outcomes of an HCV elimination program targeting the Viennese MSM population.  Wien Klin Wochenschr 133(13-14):635-640

Semmler G; Pomej K; Bauer DJM; Balcar L; Simbrunner B; Binter T; Hartl L; Becker J; Pinter M; Quehenberger P; Trauner M; Mandorfer M; Lisman T; Reiberger T; Scheiner B, 2021. Safety of direct oral anticoagulants in patients with advanced liver disease.  Liver Int 41(9):2159-2170

Simbrunner B; Trauner M; Reiberger T; Mandorfer M, 2021. Recent advances in the understanding and management of hepatorenal syndrome.  Fac Rev 10:48

Balcar L; Semmler G; Pomej K; Simbrunner B; Bauer D; Hartl L; Jachs M; Paternostro R; Bucsics T; Pinter M; Trauner M; Mandorfer M; Reiberger T; Scheiner B, 2021. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure.  United European Gastroenterol J 9(4):427-437

Hartl L; Jachs M; Desbalmes C; Schaufler D; Simbrunner B; Paternostro R; Schwabl P; Bauer DJM; Semmler G; Scheiner B; Bucsics T; Eigenbauer E; Marculescu R; Szekeres T; Peck-Radosavljevic M; Kastl S; Trauner M; Mandorfer M; Reiberger T, 2021. The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes.  Hepatol Int 15(5):1160-1173

Schmidbauer C; Chromy D; Schmidbauer V; Bauer D; Apata M; Nguyen D; Mandorfer M; Simbrunner B; Rieger A; Mayer F; Schmidt R; Holzmann H; Trauner M; Gschwantler M; Reiberger T, 2020. Epidemiological trends in HCV transmission and prevalence in the Viennese HIV+ population.  Liver Int 40(4):787-796

Scheiner B; Semmler G; Maurer F; Schwabl P; Bucsics TA; Paternostro R; Bauer D; Simbrunner B; Trauner M; Mandorfer M; Reiberger T, 2020. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease.  Liver Int 40(1):194-204

Bastati N; Beer L; Mandorfer M; Poetter-Lang S; Tamandl D; Bican Y; Elmer MC; Einspieler H; Semmler G; Simbrunner B; Weber M; Hodge JC; Vernuccio F; Sirlin C; Reiberger T; Ba-Ssalamah A, 2020. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?  Radiology 294(1):98-107

Simbrunner B; Beer A; Wöran K; Schmitz F; Primas C; Wewalka M; Pinter M; Dolak W; Scheiner B; Puespoek A; Trauner M; Oberhuber G; Mandorfer M; Reiberger T, 2020. Portal hypertensive gastropathy is associated with iron deficiency anemia.  Wien Klin Wochenschr 132(1-2):1-11

Scheiner B; Stättermayer AF; Schwabl P; Bucsics T; Paternostro R; Bauer D; Simbrunner B; Schmidt R; Marculescu R; Ferlitsch A; Peck-Radosavljevic M; Pinter M; Trauner M; Reiberger T; Ferenci P; Mandorfer M, 2020. Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension.  Liver Int 40(2):393-404

Simbrunner B; Marculescu R; Scheiner B; Schwabl P; Bucsics T; Stadlmann A; Bauer DJM; Paternostro R; Eigenbauer E; Pinter M; Stättermayer AF; Trauner M; Mandorfer M; Reiberger T, 2020. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.  Liver Int 40(7):1713-1724

Semmler G; Wöran K; Scheiner B; Unger LW; Paternostro R; Stift J; Schwabl P; Bucsics T; Bauer D; Simbrunner B; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M, 2020. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.  United European Gastroenterol J 8(3):321-331

Simbrunner B; Semmler G; Stadlmann A; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Bauer D; Eigenbauer E; Pinter M; Stättermayer AF; Quehenberger P; Marculescu R; Trauner M; Mandorfer M; Reiberger T, 2020. Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis.  Hepatol Int 14(6):1093-1103

Beer L; Bastati N; Ba-Ssalamah A; Pötter-Lang S; Lampichler K; Bican Y; Lauber D; Hodge J; Binter T; Pomej K; Simbrunner B; Semmler G; Trauner M; Mandorfer M; Reiberger T, 2020. MRI-defined sarcopenia predicts mortality in patients with chronic liver disease.  Liver Int 40(11):2797-2807

Stift J; Semmler G; Wöran K; Simbrunner B; Scheiner B; Schwabl P; Paternostro R; Pinter M; Stättermayer AF; Meischl T; Beer A; Trauner M; Mandorfer M; Reiberger T, 2020. Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy.  Dig Liver Dis 52(12):1473-1479

Raeven P; Baron-Stefaniak J; Simbrunner B; Stadlmann A; Schwabl P; Scheiner B; Schaden E; Eigenbauer E; Quehenberger P; Mandorfer M; Baron DM; Reiberger T, 2020. Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension.  Hepatol Int 14(6):1083-1092

Wöran K; Semmler G; Jachs M; Simbrunner B; Bauer DJM; Binter T; Pomej K; Stättermayer AF; Schwabl P; Bucsics T; Paternostro R; Lampichler K; Pinter M; Trauner M; Mandorfer M; Stift J; Reiberger T; Scheiner B, 2020. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension.  Clin Gastroenterol Hepatol.

Simbrunner B; Mandorfer M; Trauner M; Reiberger T, 2019. Gut-liver axis signaling in portal hypertension.  World J Gastroenterol 25(39):5897-5917

Simbrunner B; Röthenbacher A; Haslacher H; Bauer D; Chromy D; Bucsics T; Schwabl P; Paternostro R; Scheiner B; Trauner M; Mandorfer M; Schwarzinger I; Reiberger T, 2019. Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites.  United European Gastroenterol J 7(5):651-661

Semmler G; Simbrunner B; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Bauer D; Pinter M; Ferenci P; Trauner M; Mandorfer M; Reiberger T, 2019. Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.  J Gastroenterol Hepatol 34(12):2164-2172

Beer L; Mandorfer M; Bastati N; Poetter-Lang S; Tamandl D; Stoyanova DP; Elmer MC; Semmler G; Simbrunner B; Hodge JC; Sirlin CB; Reiberger T; Ba-Ssalamah A, 2019. Inter- and intra-reader agreement for gadoxetic acid-enhanced MRI parameter readings in patients with chronic liver diseases.  Eur Radiol 29(12):6600-6610

Koban F; El-Kasaby A; Häusler C; Stockner T; Simbrunner BM; Sitte HH; Freissmuth M; Sucic S, 2015. A salt bridge linking the first intracellular loop with the C terminus facilitates the folding of the serotonin transporter.  J Biol Chem 290(21):13263-78

Publication list retrieved from NCBI using ImpactPubs